7BZ8
 
 | Template lasso peptide C24 mutant V3A | Descriptor: | lasso peptide | Authors: | Liu, X.H, Liu, T, Ma, X.J, Yu, J.H, Yang, D.H, Ma, M. | Deposit date: | 2020-04-27 | Release date: | 2021-04-28 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | Rational generation of lasso peptides based on biosynthetic gene mutations and site-selective chemical modifications. Chem Sci, 12, 2021
|
|
7BZ9
 
 | Template lasso peptide C24 mutant I4A | Descriptor: | lasso peptide | Authors: | Liu, X.H, Liu, T, Ma, X.J, Yu, J.H, Yang, D.H, Ma, M. | Deposit date: | 2020-04-27 | Release date: | 2021-04-28 | Last modified: | 2024-05-15 | Method: | SOLUTION NMR | Cite: | Rational generation of lasso peptides based on biosynthetic gene mutations and site-selective chemical modifications. Chem Sci, 12, 2021
|
|
7E4M
 
 | |
7E4O
 
 | |
7E4N
 
 | Crystal structure of Sat1646 | Descriptor: | MAGNESIUM ION, Sat1646 | Authors: | Yu, J.H, Xing, B.Y, Ma, M. | Deposit date: | 2021-02-14 | Release date: | 2021-10-06 | Last modified: | 2024-05-29 | Method: | X-RAY DIFFRACTION (1.94 Å) | Cite: | Functional characterization and structural bases of two class I diterpene synthases in pimarane-type diterpene biosynthesis Commun Chem, 4, 2021
|
|
6XYI
 
 | NMR solution structure of alpha-AnmTX- Ms11a-3 (Ms11a-3) | Descriptor: | AMS9.3.1 | Authors: | Mineev, K.S, Kornilov, F.D, Lushpa, V.A, Logashina, Y.A, Maleeva, E.E, Andreev, Y.A. | Deposit date: | 2020-01-30 | Release date: | 2021-02-10 | Last modified: | 2025-02-19 | Method: | SOLUTION NMR | Cite: | Peptides from the Sea Anemone Metridium senile with Modified Inhibitor Cystine Knot (ICK) Fold Inhibit Nicotinic Acetylcholine Receptors. Toxins, 15, 2022
|
|
7KC4
 
 | Human WLS in complex with WNT8A | Descriptor: | 1-CIS-9-OCTADECANOYL-2-CIS-9-HEXADECANOYL PHOSPHATIDYL GLYCEROL, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, CHOLESTEROL HEMISUCCINATE, ... | Authors: | Nygaard, R, Jia, Y, Kim, J, Ross, D, Parisi, G, Clarke, O.B, Virshup, D.M, Mancia, F. | Deposit date: | 2020-10-05 | Release date: | 2021-01-06 | Last modified: | 2024-10-09 | Method: | ELECTRON MICROSCOPY (3.19 Å) | Cite: | Structural Basis of WLS/Evi-Mediated Wnt Transport and Secretion. Cell, 184, 2021
|
|
8IPT
 
 | |
8IPR
 
 | |
8IPS
 
 | |
8IPQ
 
 | |
2PV6
 
 | HIV-1 gp41 Membrane Proximal Ectodomain Region peptide in DPC micelle | Descriptor: | Envelope glycoprotein | Authors: | Sun, Z.-Y.J, Oh, K.J, Kim, M, Reinherz, E.L, Wagner, G. | Deposit date: | 2007-05-09 | Release date: | 2008-03-18 | Last modified: | 2024-05-22 | Method: | SOLUTION NMR | Cite: | HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane Immunity, 28, 2008
|
|
7XXU
 
 | Macaca fascicularis galectin-10/Charcot-Leyden crystal protein | Descriptor: | Galectin | Authors: | Su, J.Y. | Deposit date: | 2022-05-31 | Release date: | 2023-04-12 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Glutathione disrupts galectin-10 Charcot-Leyden crystal formation to possibly ameliorate eosinophil-based diseases such as asthma. Acta Biochim.Biophys.Sin., 55, 2023
|
|
7SD5
 
 | Crystallographic structure of neutralizing antibody 10-40 in complex with SARS-CoV-2 spike receptor binding domain | Descriptor: | 10-40 Heavy chain, 10-40 Light chain, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Reddem, E.R, Casner, R.G, Shapiro, L. | Deposit date: | 2021-09-29 | Release date: | 2022-04-27 | Last modified: | 2024-10-23 | Method: | X-RAY DIFFRACTION (1.53 Å) | Cite: | An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses. Sci Transl Med, 14, 2022
|
|
7SI2
 
 | |
9DM1
 
 | Mycobacterial supercomplex malate:quinone oxidoreductase assembly | Descriptor: | (2R)-2-(hexadecanoyloxy)-3-{[(S)-hydroxy{[(1R,2R,3R,4R,5R,6S)-2,3,4,5,6-pentahydroxycyclohexyl]oxy}phosphoryl]oxy}propyl (9S)-9-methyloctadecanoate, (2R)-3-(((2-aminoethoxy)(hydroxy)phosphoryl)oxy)-2-(palmitoyloxy)propyl (E)-octadec-9-enoate, (2S)-1-(hexadecanoyloxy)propan-2-yl (10S)-10-methyloctadecanoate, ... | Authors: | Di Trani, J.M, Rubinstein, J.L. | Deposit date: | 2024-09-11 | Release date: | 2024-10-23 | Last modified: | 2025-03-05 | Method: | ELECTRON MICROSCOPY (3.2 Å) | Cite: | Cryo-EM of native membranes reveals an intimate connection between the Krebs cycle and aerobic respiration in mycobacteria. Proc.Natl.Acad.Sci.USA, 122, 2025
|
|
7XXY
 
 | Macaca mulatta galectin-10/Charcot-Leyden crystal protein with lactose | Descriptor: | Galectin-10/Charcot-Leyden crystal protein, beta-D-galactopyranose-(1-4)-beta-D-glucopyranose | Authors: | Su, J.Y. | Deposit date: | 2022-05-31 | Release date: | 2023-04-12 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.92 Å) | Cite: | Glutathione disrupts galectin-10 Charcot-Leyden crystal formation to possibly ameliorate eosinophil-based diseases such as asthma. Acta Biochim.Biophys.Sin., 55, 2023
|
|
9EH4
 
 | Solution structure of alpha conotoxin LvID | Descriptor: | Alpha conotoxin LvID | Authors: | Harvey, P.J, Craik, D.J. | Deposit date: | 2024-11-22 | Release date: | 2025-04-23 | Last modified: | 2025-05-07 | Method: | SOLUTION NMR | Cite: | Selective Inhibition of Rat alpha 7 Nicotinic Acetylcholine Receptors by LvID, a Newly Characterized alpha 4/7-Conotoxin from Conus lividus . J.Med.Chem., 68, 2025
|
|
7XXX
 
 | Macaca mulatta galectin-10/Charcot-Leyden crystal protein | Descriptor: | Galectin-10/Charcot-Leyden crystal protein | Authors: | Su, J.Y. | Deposit date: | 2022-05-31 | Release date: | 2023-04-12 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.94 Å) | Cite: | Glutathione disrupts galectin-10 Charcot-Leyden crystal formation to possibly ameliorate eosinophil-based diseases such as asthma. Acta Biochim.Biophys.Sin., 55, 2023
|
|
7XXZ
 
 | Macaca mulatta galectin-10/Charcot-Leyden crystal protein with glycerol | Descriptor: | GLYCEROL, Galectin-10/Charcot-Leyden crystal protein | Authors: | Su, J.Y. | Deposit date: | 2022-05-31 | Release date: | 2023-04-12 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.83 Å) | Cite: | Glutathione disrupts galectin-10 Charcot-Leyden crystal formation to possibly ameliorate eosinophil-based diseases such as asthma. Acta Biochim.Biophys.Sin., 55, 2023
|
|
7XXW
 
 | |
7XXV
 
 | Macaca fascicularis galectin-10/Charcot-Leyden crystal protein with lactose | Descriptor: | Galectin, beta-D-galactopyranose-(1-4)-beta-D-glucopyranose | Authors: | Su, J.Y. | Deposit date: | 2022-05-31 | Release date: | 2023-04-12 | Last modified: | 2023-11-29 | Method: | X-RAY DIFFRACTION (1.6 Å) | Cite: | Glutathione disrupts galectin-10 Charcot-Leyden crystal formation to possibly ameliorate eosinophil-based diseases such as asthma. Acta Biochim.Biophys.Sin., 55, 2023
|
|
7TTX
 
 | |
7TTY
 
 | |
3WGJ
 
 | |